120 related articles for article (PubMed ID: 6284494)
1. A case with glucagonoma syndrome--heterogeneity of glucagon and insulin.
Fukushima H; Yamaguchi K; Uzawa H
Endocrinol Jpn; 1981 Oct; 28(5):575-82. PubMed ID: 6284494
[TBL] [Abstract][Full Text] [Related]
2. A case with glucagonoma syndrome--endocrine and metabolic studies.
Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T
Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136
[TBL] [Abstract][Full Text] [Related]
3. Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".
Recant L; Perrino PV; Bhathena SJ; Danforth DN; Lavine RL
Diabetologia; 1976 Aug; 12(4):319-26. PubMed ID: 183997
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effects of somatostatin analog (SMS 201-995) on pancreatic hormones in patients with malignant islet-cell carcinoma].
Fukushima H; Ueno S; Sakakida M; Takahashi T; Shirotani T; Araki E; Kishikawa H; Yamaguchi K; Nakamura N; Uzawa H
Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):666-76. PubMed ID: 2852126
[TBL] [Abstract][Full Text] [Related]
5. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
Drucker DJ; Asa SL; Silverberg J; Brubaker PL
Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
[TBL] [Abstract][Full Text] [Related]
7. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
Torre L; Vazquez JA; Blázquez E
Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
[TBL] [Abstract][Full Text] [Related]
9. Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor.
Kohnert KD; Kändler C; Woltanski KP; Ziegler M
Exp Clin Endocrinol; 1985 Feb; 85(1):89-94. PubMed ID: 2985414
[TBL] [Abstract][Full Text] [Related]
10. Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
Uttenthal LO; Ghiglione M; George SK; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1985 Sep; 61(3):472-9. PubMed ID: 2991321
[TBL] [Abstract][Full Text] [Related]
11. Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.
Valverde I; Lemon HM; Kessinger A; Unger RH
J Clin Endocrinol Metab; 1976 May; 42(5):804-8. PubMed ID: 178682
[TBL] [Abstract][Full Text] [Related]
12. Measurement and partial characterization of immunoreactive glucagon in gastrointestinal tissues of dogs.
Morita S; Doi K; Yip CC; Vranic M
Diabetes; 1976 Nov; 25(11):1018-25. PubMed ID: 186345
[TBL] [Abstract][Full Text] [Related]
13. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
[TBL] [Abstract][Full Text] [Related]
14. Size heterogeneity of immunoreactive glucagon during bile-duct obstruction in the rabbit.
Sanke T
Endocrinol Jpn; 1982 Oct; 29(5):541-51. PubMed ID: 6763562
[TBL] [Abstract][Full Text] [Related]
15. Excessive circulating large molecular weight immunoreactive glucagon components in subjects with the idiopathic postprandial syndrome.
Charles MA; Waldeck N
J Clin Endocrinol Metab; 1981 Aug; 53(2):366-71. PubMed ID: 6265488
[TBL] [Abstract][Full Text] [Related]
16. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome.
Fujita J; Seino Y; Ishida H; Taminato T; Matsukura S; Horio T; Imamura S; Naito A; Tobe T; Takahashi K
Cancer; 1986 Feb; 57(4):860-5. PubMed ID: 2867823
[TBL] [Abstract][Full Text] [Related]
17. Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas.
Ohneda A; Ohneda M
Tohoku J Exp Med; 1988 Jun; 155(2):197-204. PubMed ID: 3062845
[TBL] [Abstract][Full Text] [Related]
18. Secretion of immunoreactive insulin and glucagon in hamsters bearing a transplantable insuloma.
Dunbar JC; Walsh MF; Foa PP
Diabete Metab; 1976 Dec; 2(4):165-9. PubMed ID: 190057
[TBL] [Abstract][Full Text] [Related]
19. Persistence of immunoreactive insulin, glucagon and pancreatic polypeptide in the plasma of depancreatized chickens.
Colca JR; Hazelwood RL
J Endocrinol; 1982 Mar; 92(3):317-26. PubMed ID: 7040582
[TBL] [Abstract][Full Text] [Related]
20. Effect of growth hormone on acute glucagon and insulin release.
Sirek A; Vranic M; Sirek OV; Vigas M; Policova Z
Am J Physiol; 1979 Aug; 237(2):E107-12. PubMed ID: 380363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
